*Dr. Jekwu Ozoemene Africa bears roughly a quarter of the global disease burden yet imports nearly 97 percent of its pharmaceutical commodities, a vulnerability starkly exposed during the COVID-19 pandemic. This severe import dependence leaves Nigeria’s medicine security inherently weak. To address this, The Alternative Bank (AltBank) is stepping in as the financing answer, deploying asset-backed, risk-sharing capital to fund local pharmaceutical production, distribution, and supply chains. As part of this effort, the Bank has extended an invitation to Industrial Pharmacists across Nigeria to partner on solutions. Speaking in a…
Read More